Shareholder Votes

Weatherford International plc shareholders approved Authorization to allot and issue new ordinary shares to Weatherford-US in connection with the Scheme at the 2026-06-11 meeting.

“10. The shareholders voted as follows to authorize the directors of Weatherford-Ireland to allot and issue new Weatherford-Ireland ordinary shares to Weatherford-US and/or its nominee(s) in an amount equal to the number of Weatherford-Ireland ordinary shares cancelled in connection with the Scheme of Arrangement and the application of the reserve cre”

Weatherford International plc shareholders rejected Approval of terms of initial subscription, allotment and issue of ordinary shares to Weatherford-US in connection with the Scheme at the 2026-06-11 meeting.

“9. The shareholders did not vote to approve the terms of an initial subscription, allotment and issue of one, or more, Weatherford-Ireland ordinary shares to Weatherford-US in connection with the Scheme of Arrangement. For Against Abstain Broker Non-Votes 41,870,302 22,850,999 37,472 2,445,655”

Weatherford International plc shareholders rejected Approval of capital reduction to cancel ordinary shares under the Scheme of Arrangement at the 2026-06-11 meeting.

“8. The shareholders did not vote to approve a capital reduction under sections 84 to 86 of the Companies Act to effect the cancellation of Weatherford-Ireland ordinary shares contemplated by the Scheme of Arrangement. For Against Abstain Broker Non-Votes 41,338,423 23,395,869 24,481 2,445,655”

Weatherford International plc shareholders rejected Approval of Scheme of Arrangement to redomesticate from Ireland to Texas at the 2026-06-11 meeting.

“7. The shareholders voted as follows to approve the Scheme of Arrangement by, and on behalf of, the Company, and to authorize the directors of the Company to take all such actions as they consider necessary or appropriate to carry the Scheme of Arrangement into effect. For Against Abstain Broker Non-Votes 39,473,706 25,247,441 37,626 2,445,655”

Weatherford International plc shareholders approved Grant of authority to Board to opt-out of statutory preemption rights under Irish law at the 2026-06-11 meeting.

“6. The shareholders voted as follows to grant the Board of Directors the authority to opt-out of statutory preemption rights under Irish law. For Against Abstain Broker Non-Votes 64,317,149 417,018 24,606 2,445,655”

Weatherford International plc shareholders approved Grant of authority to Board to issue shares under Irish law at the 2026-06-11 meeting.

“5. The shareholders voted as follows to grant the Board of Directors the authority to issue shares under Irish law. For Against Abstain Broker Non-Votes 64,464,463 272,433 21,877 2,445,655”

Weatherford International plc shareholders approved Non-binding advisory vote to approve compensation of named executive officers at the 2026-06-11 meeting.

“3. The shareholders voted as follows to approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers. For Against Abstain Broker Non-Votes 64,080,857 506,631 171,285 2,445,655”

Weatherford International plc shareholders approved Ratify appointment of KPMG LLP as independent auditor and KPMG Chartered Accountants as statutory auditor, and authorize Audit Committee to determine auditor remuneration at the 2026-06-11 meeting.

“2. The shareholders voted as follows to: (a) ratify the appointment of (i) KPMG LLP as the Company’s independent registered public accounting firm and auditor for the financial year ending December 31, 2026 and (ii) KPMG Chartered Accountants, Dublin, as the Company’s statutory auditor under Irish law to hold office until the close of the Company’s 2027 Annual General Meeting of the Shareholders; and (b) authorize the Board of Directors of the Company, acting through the Audit Committee, to determine the auditors’ remuneration. For Against Abstain Broker Non-Votes 66,727,562 453,263 23,603 —”

Weatherford International plc shareholders approved Election of six director nominees to serve a one-year term at the 2026-06-11 meeting.

“1. The shareholders voted as follows to elect each of the six director nominees to serve a one-year term that is anticipated to expire at the Company’s 2027 Annual General Meeting of the Shareholders.”

Weatherford International plc shareholders approved To approve the Weatherford International plc 2026 Equity Incentive Plan at the 2026-06-11 meeting.

“4. The shareholders voted as follows to approve the Plan. For Against Abstain Broker Non-Votes 60,282,187 4,435,782 40,804 2,445,655”

Inogen Inc shareholders rejected Amendment to Declassify the Board.

“The Company’s stockholders did not approve the amendment to the Company's Thirteenth Amended and Restated Certificate of Incorporation to declassify the Board. The votes regarding the proposal were as follows: Votes For Votes Against Abstentions Broker Non-Votes 17,883,761 154,379 235,085 2,571,716”

Inogen Inc shareholders approved Approval of the Amended and Restated 2023 Equity Incentive Plan.

“The Company’s stockholders approved the adoption of the Amended and Restated 2023 Equity Incentive Plan. The votes regarding the proposal were as follows: Votes For Votes Against Abstentions Broker Non-Votes 16,208,966 2,009,937 54,322 2,571,716”

Inogen Inc shareholders approved Advisory Vote on Executive Compensation.

“The Company’s stockholders approved the named executive officers’ compensation as disclosed in the Proxy. The votes regarding the proposal were as follows: Votes For Votes Against Abstentions Broker Non-Votes 17,316,134 921,787 35,304 2,571,716”

Inogen Inc shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-12-31 meeting.

“The appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified based on the following results of voting: Votes For Votes Against Abstentions Broker Non-Votes 20,395,716 407,035 42,190 —”

Inogen Inc shareholders approved Election of Class III Directors.

“The following nominees were elected to serve as Class III directors, to hold office until the Company’s 2029 annual meeting of stockholders or until his or her respective successor has been duly elected and qualified: Nominee Votes For Votes Withheld Broker Non-Votes Glenn Boehnlein 17,324,463 948,762 2,571,716 Mira Sahney 13,276,829 4,996,396 2,571,716”

Arq, Inc. shareholders approved To approve the Ninth Amendment to Tax Asset Protection Plan by and between the Company and Computer Share Trust Company, N.A., as rights agent.

“(5) Proposal: To approve the Ninth Amendment to Tax Asset Protection Plan by and between the Company and Computer Share Trust Company, N.A., as rights agent. Votes For Against Abstain Broker Non-Votes 20,808,187 1,530,075 23,943 9,645,289”

Arq, Inc. shareholders approved To approve the Arq, Inc. 2026 Omnibus Incentive Plan.

“(4) Proposal: To approve the Arq, Inc. 2026 Omnibus Incentive Plan. Votes For Against Abstain Broker Non-Votes 16,506,996 3,879,647 1,975,562 9,645,289”

Arq, Inc. shareholders approved Ratification of the Audit Committee's selection of Baker Tilly US, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-12-31 meeting.

“(3) Proposal: Ratification of the Audit Committee's selection of Baker Tilly US, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Votes For Against Abstain Broker Non-Votes 31,874,146 58,879 74,469 N/A”

Arq, Inc. shareholders approved To approve, on an advisory basis, of the Company's compensation paid to named executive officers.

“(2) Proposal: To approve, on an advisory basis, of the Company's compensation paid to named executive officers, as disclosed in the 2026 Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission (which includes the compensation tables and related narrative discussion). Votes For Against Abstain Broker Non-Votes 21,562,428 670,264 129,513 9,645,289”

Arq, Inc. shareholders approved Election of six directors to the Company's Board of Directors.

“(1) Proposal: Election of six directors to the Company's Board of Directors. Votes Director Name For Withheld Broker Non-Votes Laurie Bergman 21,756,739 605,466 9,645,289 Jeremy Blank 19,796,330 2,565,875 9,645,289 Richard Campbell-Breeden 21,812,209 549,996 9,645,289 Carol Eicher 21,560,459 801,746 9,645,289 Julian McIntyre 19,633,501 2,728,704 9,645,289 Robert Rasmus 19,871,142 2,491,063 9,645,289”

Aura Biosciences, Inc. shareholders approved Ratification of Appointment of Independent Registered Accounting Firm at the 2026-06-11 meeting.

“Proposal 2 - Ratification of Appointment of Independent Registered Accounting Firm The Company’s stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026. Votes For Votes Against Abstentions 52,752,601 17,348 14,795 There were zero broker non-votes regarding this proposal.”

Aura Biosciences, Inc. shareholders approved Election of Class II Directors at the 2026-06-11 meeting.

“Proposal 1 - Election of Directors The Company’s stockholders elected the two (2) director nominees below to the Company’s Board of Directors as Class II directors to serve until the 2029 Annual Meeting of Stockholders of the Company and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal. Director Nominee Votes For Votes Withheld Broker Non-Votes David Johnson 34,542,193 6,628,297 11,614,254 Teresa Marie Bitetti 40,526,332 644,158 11,614,254”

Fortive Corp shareholders approved To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026. at the 2026-06-09 meeting.

“Proposal 3 : To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026. The proposal was approved by a vote of the shareholders as follows: For 274,297,484 Against 16,324,999 Abstain 57,605”

Fortive Corp shareholders approved To approve on an advisory basis the Company’s named executive officer compensation. at the 2026-06-09 meeting.

“Proposal 2 : To approve on an advisory basis the Company’s named executive officer compensation. The proposal was approved by a vote of the shareholders as follows: For 265,946,471 Against 15,686,260 Abstain 174,890 Broker Non-Votes 8,872,467”

Fortive Corp shareholders approved Election of eight director nominees named in the Proxy Statement, each for a one-year term expiring at the 2027 annual meeting. at the 2026-06-09 meeting.

“On June 9, 2026, Fortive Corporation (the “Company”) held the annual meeting of shareholders of the Company (the “Annual Meeting”). At the Annual Meeting, the Company’s shareholders voted on the following three proposals: Proposal 1 : To elect the eight director nominees named in the Proxy Statement, each for a one-year term expiring at the 2027 annual meeting and until his or her respective successor is duly elected and qualified. Each nominee for director was elected by a vote of the shareholders as follows: For Against Abstain Broker Non-Votes Daniel L. Comas 278,928,126 2,820,139 59,356 8,872,467 Sharmistha Dubey 275,112,249 6,634,401 60,971 8,872,467 Rejji P. Hayes 279,148,160 2,599,621 59,840 8,872,467 Wright L. Lassiter III 278,900,251 2,847,808 59,562 8,872,467 Kate D. Mitchell 271,853,197 9,895,494 58,930 8,872,467 Gregory J. Moore 276,246,284 5,501,447 59,890 8,872,467 Jeannine Sargent 268,819,357 12,929,179 59,085 8,872,467 Olumide Soroye 281,242,738 504,101 60,782 8,872,467”

Instil Bio, Inc. shareholders approved Ratification of RSM US LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-11 meeting.

“Stockholders ratified the selection by the Audit Committee of the Board of RSM US LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”

Instil Bio, Inc. shareholders approved Election of Class II directors at the 2026-06-11 meeting.

“Stockholders elected the following nominees to serve as Class II directors on the Company’s board of directors (the “Board”) until the Company’s 2029 Annual Meeting of Stockholders and until his successor has been duly elected and qualified.”

Omega Flex, Inc. shareholders approved Election of three class 3 directors for a three-year term at the 2026-06-10 meeting.

“On June 10, 2026, Omega Flex, Inc. (the “Company”) held its Annual Meeting of Shareholders at which one proposal was voted upon: 1. Election of three class 3 directors for a three-year term.”

Bowen Acquisition Corp shareholders approved Extension Proposal to amend the Company's Articles to extend the date to consummate a business combination at the 2026-06-11 meeting.

“On June 11, 2026, Bowen Acquisition Corp (the “Company”) held an extraordinary general meeting (the “Meeting”) to approve, by special resolution and pursuant to the terms of the Company’s amended and restated memorandum and articles of association, as amended (the “Articles”), an amendment to the Articles to allow the board of directors of the Company (the “Board”) to extend the date (the “Extension”) by which the Company must consummate an initial merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (a “business combination”).”

Jade Biosciences, Inc. shareholders approved Approve an amendment to the Company’s Articles of Incorporation to waive jury trials in certain circumstances at the 2026-06-09 meeting.

“Proposal to approve an amendment to the Company’s Articles of Incorporation to waive jury trials in certain circumstances. The proposal was approved by the votes indicated: For Against Abstain Broker Non-Votes 39,933,495 2,481,659 235 3,591,287”

Jade Biosciences, Inc. shareholders approved Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-09 meeting.

“Proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The appointment was ratified by the votes indicated: For Against Abstain Broker Non-Votes 46,003,217 3,322 137 0”

Jade Biosciences, Inc. shareholders approved Election of two Class II Directors to serve until the 2029 Annual Meeting of Stockholders at the 2026-06-09 meeting.

“The following two Class II Directors were elected by the votes indicated: For Withheld Broker Non-Votes Christopher Cain, Ph.D. 34,373,784 8,041,605 3,591,287 Tom Frohlich 42,399,190 16,199 3,591,287”

TXNM ENERGY INC shareholders approved Advisory vote to approve the compensation of TXNM’s NEOs at the 2026-06-10 meeting.

“TXNM's shareholders approved, on an advisory basis, the compensation of TXNM’s NEOs, by the vote indicated below: Votes For Votes Against Abstentions Broker Non-Votes 88,014,281 1,167,803 156,227 8,334,413”

TXNM ENERGY INC shareholders approved Ratification of KPMG LLP as TXNM’s independent public accountants for the year ending December 31, 2026 at the 2026-06-10 meeting.

“The appointment of KPMG LLP to serve as TXNM’s independent public accountants for the year ending December 31, 2026, was ratified by TXNM’s shareholders by the vote indicated below: Votes For Votes Against Abstentions 97,185,638 356,222 130,864”

TXNM ENERGY INC shareholders approved Election of 10 directors to serve for a one-year term expiring in 2027 at the 2026-06-10 meeting.

“The following nominees were elected to TXNM’s Board of Directors to serve as directors for a one-year term that expires at TXNM’s Annual Meeting of Shareholders to be held in 2027. The votes cast with respect to the nominees presented at the Meeting were as follows: Nominees Votes For Votes Against Abstentions Broker Non-Votes Vicky A. Bailey 88,707,042 525,533 105,736 8,334,413 Norman P. Becker 88,872,216 348,411 117,684 8,334,413 Patricia K. Collawn 87,848,176 1,378,787 111,348 8,334,413 E. Renae Conley 88,179,291 1,053,246 105,774 8,334,413 Sidney M. Gutierrez 88,657,040 565,794 115,477 8,334,413 James A. Hughes 88,735,931 471,779 130,601 8,334,413 Steven C. Maestas 89,063,640 165,870 108,801 8,334,413 Lillian J. Montoya 88,794,924 435,066 108,321 8,334,413 Maureen T. Mullarkey 88,242,541 990,345 105,425 8,334,413 Joseph D. Tarry 88,884,448 342,093 111,770 8,334,413”

Yext, Inc. shareholders approved Approval of the 2016 Equity Incentive Plan, as amended, restated and extended at the 2026-06-10 meeting.

“The Plan was approved by the following vote: For Against Abstain Broker Non-Votes 48,430,077 14,448,832 161,655 10,828,010”

Yext, Inc. shareholders approved Advisory approval of named executive officer compensation at the 2026-06-10 meeting.

“The compensation of the Company’s named executive officers was approved on an advisory, non-binding basis by the following vote: For Against Abstain Broker Non-Votes 59,780,340 3,163,149 97,075 10,828,010”

Yext, Inc. shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm at the 2026-06-10 meeting.

“The appointment of Ernst & Young LLP to serve as the Company’s independent registered public accounting firm for the fiscal year ending January 31, 2027 was ratified by the following vote: For Against Abstain 72,769,470 738,784 360,320”

Yext, Inc. shareholders approved Election of Class III directors at the 2026-06-10 meeting.

“Each of the two nominees received the affirmative majority of votes cast with respect to that director and were elected as the Class III directors by the following vote: Director Nominee For Against Abstain Broker Non-Votes Daniel Englander 61,538,851 1,389,188 112,525 10,828,010 Andrew Sheehan 42,086,549 20,839,792 114,223 10,828,010”

Genie Energy Ltd. shareholders approved Approval of an amendment to the 2021 Stock Option and Incentive Plan that increased the number of shares of the Company’s Class B common stock available for grant by 70,000 at the 2026-06-10 meeting.

“A majority of the votes present or represented at the Meeting by the holders of shares entitled to vote on the following matter were voted in connection with the approval of an amendment to the 2021 Stock Option and Incentive Plan that increased the number of shares of the Company’s Class B common stock available for the grant of awards thereunder by 70,000. The number of votes cast with respect to this matter was as follows: Votes For Votes Against Abstentions Broker Non-Vote % Votes For 5,930,700 731,723 31,247 0 88.60”

Genie Energy Ltd. shareholders approved Election of Directors at the 2026-06-10 meeting.

“The nominees for election to the Board of Directors were elected, each for a one-year term, based upon the following votes: Nominee Votes For Votes Against Abstentions Broker Non-Vote % Votes For Howard S. Jonas 6,149,669 514,052 29,950 0 91.87 Irwin Katsof 6,686,724 4,809 2,138 0 99.90 Joyce Mason 6,680,573 10,918 2,180 0 99.80 W. Wesley Perry 6,359,758 302,266 31,646 0 95.01 Alan B. Rosenthal 6,340,525 321,513 31,632 0 94.72”

Alphabet Inc. shareholders rejected Shareholder proposal regarding AI Board oversight.

“A shareholder proposal regarding AI Board oversight was not approved.”

Alphabet Inc. shareholders rejected Shareholder proposal regarding a report on data privacy.

“A shareholder proposal regarding a report on data privacy was not approved.”

Alphabet Inc. shareholders rejected Shareholder proposal regarding a report on impact of U.S. immigration policy.

“A shareholder proposal regarding a report on impact of U.S. immigration policy was not approved.”

Alphabet Inc. shareholders rejected Shareholder proposal regarding a report on politicized content moderation.

“A shareholder proposal regarding a report on politicized content moderation was not approved.”

Alphabet Inc. shareholders rejected Shareholder proposal regarding a viewpoint diversity risk report.

“A shareholder proposal regarding a viewpoint diversity risk report was not approved.”

Alphabet Inc. shareholders rejected Shareholder proposal regarding equal shareholder voting.

“A shareholder proposal regarding equal shareholder voting was not approved.”

Alphabet Inc. shareholders rejected Shareholder proposal regarding a report on water usage and AI development.

“A shareholder proposal regarding a report on water usage and AI development was not approved.”

Alphabet Inc. shareholders rejected Shareholder proposal regarding enhanced disclosure on climate goals.

“A shareholder proposal regarding an enhanced disclosure on climate goals was not approved.”

Alphabet Inc. shareholders approved Advisory vote on compensation awarded to Alphabet’s named executive officers.

“The compensation awarded to Alphabet’s named executive officers, as described in the 2026 Proxy Statement, was approved, on an advisory basis.”